glu-asp-arg and Central-Nervous-System-Diseases

glu-asp-arg has been researched along with Central-Nervous-System-Diseases* in 1 studies

Reviews

1 review(s) available for glu-asp-arg and Central-Nervous-System-Diseases

Article	Year
[Neuroprotective effects of peptides bioregulators in people of various age]. Advances in gerontology = Uspekhi gerontologii, 2013, Volume: 26, Issue:4 The review presents comparative characteristics of 2 peptide neuroprotective groups: polypeptide complexes (cortexin, cerebrolizin) and short peptides (semax, kortagen, pinealon). The data of clinical applying of peptides in elderly and old age people and cellular and molecular mechanisms of their neuroprotective activity is described. Topics: Adrenocorticotropic Hormone; Aged; Amino Acids; Brain; Cellular Senescence; Central Nervous System Diseases; Humans; Intercellular Signaling Peptides and Proteins; Neuroprotective Agents; Oligopeptides; Outcome Assessment, Health Care; Peptide Fragments; Peptides; Randomized Controlled Trials as Topic	2013

Article

Year

[Neuroprotective effects of peptides bioregulators in people of various age].

Advances in gerontology = Uspekhi gerontologii, 2013, Volume: 26, Issue:4

The review presents comparative characteristics of 2 peptide neuroprotective groups: polypeptide complexes (cortexin, cerebrolizin) and short peptides (semax, kortagen, pinealon). The data of clinical applying of peptides in elderly and old age people and cellular and molecular mechanisms of their neuroprotective activity is described.

Topics: Adrenocorticotropic Hormone; Aged; Amino Acids; Brain; Cellular Senescence; Central Nervous System Diseases; Humans; Intercellular Signaling Peptides and Proteins; Neuroprotective Agents; Oligopeptides; Outcome Assessment, Health Care; Peptide Fragments; Peptides; Randomized Controlled Trials as Topic

2013